Further Information Disclaimer

Reprogenetics demonstrates that patients with recurrent pregnancy loss can benefit from PGD

The objective of the study was to determine if Preimplantation Genetic Diagnosis (PGD) and transfer of chromosomally normal embryos would decrease spontaneous abortion rates in patients suffering from recurrent pregnancy loss (RPL).   RPL patients having three or more prior lost pregnancies with no known etiology were recruited for the study. Biopsy of a single blastomere from each day-3 embryo was performed followed by chromosome analysis of the biopsied cell. Only embryos classified as chromosomally normal were replaced. The rate of spontaneous abortions in RPL subjects undergoing PGD were compared to 1) their own a priori expectations, based on Brigham et al. (1999) and 2) a "comparison" group of women undergoing PGD for advanced maternal age (35 y or older).

The results were that before PGD, RPL patients had lost 87% (262/301) of their pregnancies, with an expected loss rate of 36.5%.   After PGD they only lost 16.7% pregnancies, which was statistically significant.   This difference was mostly due to reduction in pregnancy loss in the >= 35-age subgroup, to 12% from an expected 44.5% (p=0.007).  

Thus in conclusion, PGD has a beneficial effect on pregnancy outcome in RPL couples, especially >= 35 years of age.   Our data indicate that PGD reduces the risk of miscarriage in RPL patients to baseline levels.   | Read

BREAKING NEWS
Reprogenetics reaches 5000 cycles of PGD performed

The article is coming soon

See the abstracts presented by Reprogenetics at the PGDIS meeting (London)
Microarray technology to assess gene expression profiles... | Read

PGD DIAGNOSIS
Reprogenetics provides PGD analysis to IVF centers, including PGD of aneuploidy for advanced maternal age (such as Down syndrome), repeated IVF failure, recurrent spontaneous abortions, chromosome translocations and inversions, as well as PGD for gene defects such as Cystic fibrosis, fragile X, Myotonic Dystrophy, Thalasaemia, Tay Sachs, and others. We also provide embryologist that can perform embryo biopsy and cell processing.  
GENETIC COUNSELING FOR PATIENTS
Patients interested in PGD services could contact an IVF center for which we provide services or directly contact our genetic counselor for an in depth discussion of your case.
ASSOCIATIONS
www.IVFonline.com
www.LifeGlobal.com
www.ivflabs.com


MORE STORIES
Reprogenetics obtains a license to perform PGD in NY state for any type of PGD
Dear Colleague: In July of 2003, laboratories and assisted reproductive technology (ART) providers were notified that a New York State laboratory permit would be required for facilities performing preimplantation genetic diagnosis (PGD) on single cells derived from embryos by molecular genetic and/or cytogenetic techniques. |
Read
 
HOME >>>
 

Reprogenetics
© Copyright 2001 Janus Net Technology, Inc. All rights reserved.
Refering IVF Centers Home Contact Us Further Information Disclaimers about PGD